BSE filing, NSE: AMBER. Summary written from the filing by ALFA Finder's alert engine.
Amber Enterprises India Ltd: key numbers
- Share price
- ₹5,865.00
- Market cap
- ₹20,685 Cr
- Revenue (annual)
- ₹12,186 Cr
- Net profit (annual)
- ₹177.7 Cr
- P/E (TTM)
- 269.1×Sector 40.5×
- Promoter holding
- 38.09%+0.00% QoQ
- FII holding
- 20.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amber Enterprises India Ltd
All →Amber Enterprises India Acquisition Worth ₹176 Cr
Amber Enterprises' subsidiary IL JIN will acquire the remaining 40% stake in Power-One for ₹176 Crore via a share swap, achieving full ownership.
- Value
- ₹176.0 Cr
Amber Enterprises India Acquisition Worth ₹13.12 Cr
Amber's subsidiary IL JIN Electronics will acquire the remaining 1.50% stake in Ascent Circuits, making it a wholly-owned subsidiary via a ₹13.12 Crore share swap.
- Value
- ₹13.12 Cr
- Execution
- 10 Business Days from the Execution Date
Amber Enterprises India Management Change
Amber Enterprises' subsidiary, IL JIN Electronics, appointed Mr. Satendra Singh as CEO and Whole-Time Director, while Mr. Sanjay Kumar Arora ceased his directorship.
Amber Enterprises India Other Announcement
Amber Enterprises India Ltd filed a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th September 2026.
Amber Enterprises India Merger & Restructuring Worth ₹0.01 Cr
Amber Enterprises India incorporated Amber Digital Technologies Pvt Ltd, a 100% subsidiary, to begin mobile phone manufacturing. Funded with ₹0.01 Crore subscription money in India.
- Value
- ₹0.01 Cr
Amber Enterprises India Capacity Expansion: ₹0.01 Cr Investment
Amber Enterprises incorporated subsidiary Amber Digital Technologies to enter mobile phone manufacturing. Initial subscription of ₹0.01 Crore was infused for this new electronics and telecom venture.
- Value
- ₹0.01 Cr
Other board meeting date announcements
All →Lotus Eye Hospital and Institute Board Meeting Date
Lotus Eye Hospital intimated that its Board meeting is scheduled for 11/11/2026 to consider unaudited Q2/H1 results. The trading window will reopen after results declaration.
Purple Agrotech Industries Board Meeting Date
Purple Agrotech Industries has scheduled a Board meeting on 5 November 2026 to consider Q2 FY27 standalone results. No financial figures are disclosed in this advance intimation.
Man Industries (India) Board Meeting Date
Man Industries scheduled a board meeting for 12 Nov 2026 to consider unaudited Q2/H1 FY27 results. No financial figures or decisions are reported in this advance notice.
JNK India Board Meeting Date
JNK India Ltd scheduled its Board for November 5, 2026 to consider Q1 and H1 FY27 unaudited results. The trading window remains closed pending results declaration.
Mercantile Ventures Board Meeting Date
Mercantile Ventures scheduled its Board meeting for 06 November 2026. It will consider unaudited quarterly and half-year results through 30 September 2026.
Anand Seamless Board Meeting Date
Anand Seamless Ltd intimated BSE of its Board meeting scheduled for 5 November 2026 to consider half-year financial results. The filing also notes the trading window closure period tied to the results declaration.